Overview
What is Society Of Urologic Oncology Clinical Trials Consortium?
The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) is a collaborative network of leading uro-oncologists, both academic and community-based, dedicated to enhancing urology research and pharmaceutical trials. Their mission is multifaceted, focusing on improving disease education and management for better patient outcomes, providing professional education to further knowledge within the field, and keeping clinicians informed about existing research that advances clinical education and hypotheses. The consortium aids doctors and hospitals conducting clinical trials by offering expedited concept and protocol review, standardized language, and centralized data management, enabling the testing of needed therapies more rapidly. Revenues generated from sponsor agreements are used to fund the collective academic, research, corporate, and administrative objectives of the consortium. The SUO-CTC provides a variety of value-added services that benefit the uro-oncology community and the pharmaceutical industry globally.
Official website here: www.suoctc.org
Is Society Of Urologic Oncology Clinical Trials Consortium legitimate?
Society Of Urologic Oncology Clinical Trials Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Society Of Urologic Oncology Clinical Trials Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.suoctc.org
What is the mission statement of Society Of Urologic Oncology Clinical Trials Consortium?
The Society of Urologic Oncology Clinical Trials Consortium is a national alliance of leading academic and community-based uro-oncologists. Their mission is threefold. Firstly, they aim to advance urology research and pharmaceutical trials to improve disease management and patient outcomes. Secondly, they provide education to both patients and the medical profession, fostering better learning and awareness. Lastly, they keep clinicians informed about existing research that can further clinical education and hypotheses, thereby contributing to the field of urologic oncology.
Official website here: www.suoctc.org
Who is the CEO of Society Of Urologic Oncology Clinical Trials Consortium?
Dr Michael Edward Woods Md is the President of Society Of Urologic Oncology Clinical Trials Consortium.
Official website here: www.suoctc.org
What is the revenue of Society Of Urologic Oncology Clinical Trials Consortium?
Society Of Urologic Oncology Clinical Trials Consortium's revenue in 2022 was $626,645.
Official website here: www.suoctc.org
Who are the executives of Society Of Urologic Oncology Clinical Trials Consortium and what are their salaries?
- Gennady Bratslavsky Md (President) [Trustee/Director]
- Michael Edward Woods Md Facs (Treasurer) [Trustee/Director]
- Robert Guy Uzzo Md Mba Facs (Past President) [Trustee/Director]
- Sam S Chang Md Mba (Director)
- Jeffrey Maxwell Holzbeierlein (Director)
- Adam Stuart Kibel Md (Director)
- Daniel W Lin Md (Director)
- W Marston Linehan Md (Director)
- Kelly L Stratton Md Fac (Director)
- Ms Pam Murphy (Executive Dir.)
Official website here: www.suoctc.org
Where can I find the form 990 for Society Of Urologic Oncology Clinical Trials Consortium?
The Society Of Urologic Oncology Clinical Trials Consortium’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.suoctc.org
Learn more at the official website: www.suoctc.org
Mission Statement of Society Of Urologic Oncology Clinical Trials Consortium
The Society of Urologic Oncology Clinical Trials Consortium is a nationwide alliance of leading uro-oncologists, committed to advancing urology research and pharmaceutical trials. Their mission is twofold: firstly, they strive to offer the best possible approach to disease education and management, aiming for improved patient outcomes. Secondly, they provide education for the medical profession, building upon the learnings derived from their research to further advance clinical education and hypotheses. The consortium also seeks to keep clinicians informed about existing research, thereby enhancing their clinical education and fostering a deeper understanding of the field.
Impact
This information is meant to be a general summary of Society Of Urologic Oncology Clinical Trials Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.
Wednesday, July 24, 2024
The Society Of Urologic Oncology Clinical Trials Consortium plays a crucial role in advancing urology research and pharmaceutical trials. By facilitating expedited concept and protocol reviews, providing standardized protocol and contract language, and offering centralized data management, the consortium enables doctors and hospitals to conduct clinical trials more efficiently. This streamlined process helps test needed therapies more rapidly, ultimately contributing to improved patient outcomes. Additionally, the consortium directs revenues from sponsor agreements towards funding academic, research, corporate, and administrative objectives, benefiting the uro-oncology community and the pharmaceutical industry. This collaborative approach not only enhances clinical education and hypotheses but also supports the development of innovative treatments in urologic oncology.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CLINICAL TRIAL SPONSORS
Revenue
$626,645
Organization Details
Founding Year
2008
Phone
(847) 517-7225
Principal Officer
Dr Michael Edward Woods Md
Main Address
1100 E WOODFIELD RD 350, SCHAUMBURG, IL, 60173
Website
www.suoctc.org
NTEE Category
Code: H30 - Medical research
If you are a representative of Society Of Urologic Oncology Clinical Trials Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.